AGER and chronic myelogenous leukemia, BCR-ABL1 positive: This limitation is particularly relevant when interpreting the effects of CML, as protein modifications, such as AGE formation and RAGE activation, could have downstream consequences on protein function, cellular signaling, and osteocyte behavior.